期刊文献+

曲美他嗪治疗风湿性心脏病慢性心力衰竭的临床价值探讨 被引量:8

暂未订购
导出
摘要 目的探讨曲美他嗪治疗风湿性心脏病慢性心力衰竭的临床价值。方法选取我院2010年5月—2013年2月收治的风湿性心脏病慢性心力衰竭患者80例,按随机数字表法分为对照组和观察组,每组40例。对照组给予一般常规治疗,观察组在一般常规治疗基础上加用曲美他嗪佐治疗。治疗3个月后,评价两组患者的疗效。结果对照组临床治疗总有效率62.5%,观察组为92.5%。观察组临床疗效有与对照组,差异有统计学意义(P<0.05)。两组患者治疗前后心功能分级和左室射血分数(LVEF)比较,差异无统计学意义(P>0.05),但是治疗后观察组患者的心功能分级和LVEF均小于对照组,差异有统计学意义(P<0.05)。结论曲美他嗪治疗风湿性心脏病慢性心力衰竭疗效确切,值得临床推广应用。
出处 《临床合理用药杂志》 2013年第33期32-33,共2页 Chinese Journal of Clinical Rational Drug Use
  • 相关文献

参考文献8

二级参考文献22

  • 1张子彬.心力衰竭的新概念及诊疗新进展[J].滨州医学院学报,1994,17(2):179-182. 被引量:2
  • 2Banach M, Rysz J, Goch A, et al. The Role of Trimetazidine After Acute Myocardial Infarclion[J]. Current Vascular Pharmacology, 2008,6:282.
  • 3Ruzyllo W, Szwed H, Sadowski Z, et al. Efficacy of trime tazidine in patients with recurrent angina a subgroup analysis of the TRIMPOLⅡ study[J]. CurrMed Res Opin, 2004,20(9):1447- 1454.
  • 4Marzillim. Cardioprotective effectsoftrme tazidine A review [J]. Currmedrev,2003,19(7):661-672.
  • 5叶任高,陆月英,主编.内科学.第6版.北京:人民卫生出版社,2006:35-36.
  • 6Brauwald,陈灏珠,译.心脏病学[M].第5版.北京:人民卫生出版社,2001:458.
  • 7Brauwald,陈灏珠译.心脏病学.第5版.北京:人民卫生出版社.2001:458.
  • 8QShlyahto EV, Almazov VV , Nifontov EM, ei al. Antionginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris [J]. Am J Cardiovasc Drugs, 2002, 2 (2): 119-124.
  • 9Di Napoli P, Di Giovanni P, Geata MA, et al. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic, dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial [J]. Cardiovasc Pharmacol, 2007, 50 (5): 585-589.
  • 10Novo G, Amoroso GR, Fazio G, et al. Biomarkers in heart failure [J]. Front Biosci, 2009, 14 (1):2484-2493.

共引文献173

同被引文献43

  • 1周秀金.曲美他嗪辅助治疗风湿性心脏病慢性心力衰竭的临床价值分析[J].医学信息(医学与计算机应用),2014,0(4):168-168. 被引量:2
  • 2郭晓庆.曲美他嗪辅助治疗风湿性心脏病慢性心衰疗效观察[J].今日健康,2016,15(3):38-38. 被引量:2
  • 3Abdoul K, Mariana M, Kamadore T, et al. Echocardiographic screening for rheumatic heart disease:Age matters. International Joumal of Cardiology, 2013,168:888-891.
  • 4Sadia R, Naveed A, Nusrat S, et al. A study on the association of TNF-α- 308,IL-6-174, IL-10-1082 and IL-1RaVNTR gene polymorphisms with rheumatic heart disease in Pakistani patients. Cytokine,2013,61:527- 531.
  • 5Amit KS,Mahesh G, Deepak B, et al. Muhivalvular rheumatic heart dis- ease in case of congenital rubella syndrome with congenital valvular pul- monary stenosis. Journal of Indian College of Cardiology,2013,3:143- 145.
  • 6Soumya P, Jayashree K, Ashalatha B, et al. A patient with rheumatic heart disease presented with central cyanosis due to acquired methemoglobin- emia during late pregnancy A rare association. Journal of Cardiovascu- lar Disease Research,2013,4:147-148.
  • 7Babua C, Kalyesubula R,Okello E,et al. Pattern and presentation of cardiac diseases among patients with chronic kidney disease attending a national referral hospital in Uganda: a cross sectional study [J]. BMC Neph- rol,2015,16(1) :l-6.
  • 8Saxena A. Evaluation of acquired valvular heart disease by the pediatrician : when to follow, when to refer for intervention? Part I [ J ]. Indian J Pediatr, 2015,82 ( 11 ): 1033-1041.
  • 9Dillon J, Yakub MA,Kong PK,et al. Comparative longterm results of mitral valve repair in adults with chronic rheumatic disease and degenerative disease : is repair for ''burnt-out" rheumatic disease still inferior to repair for degenerative disease in the current era? [ J ]. J Thorac Cardiovasc Surg,2015,149(3) :771-779.
  • 10Harikrishnan S,Sanjay G,Anees T,et al. Clinical pres-entation ,management, in - hospital and 90 - day outcomes of heart failure patients in Trivandrum, Kerala, India: the Trivandrum Heart Failure Registry[ J]. Eur J Heart Fail,2015,17(8) :794-800.

引证文献8

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部